Epidemiology
Etiology
Pathophysiology
- Point mutation in the β-globin gene (chromosome 11) → glutamic acid replaced with valine (single amino acid substitution) → 2 α-globin and 2 mutated β-globin subunits create pathological hemoglobin S (HbS).
- Heterozygotes (HbAS): carry one sickle allele and one other (usually normal) → sickle cell trait
- Homozygotes (HbSS): carry two sickle alleles → sickle cell anemia
- HbS polymerizes when deoxygenated, causing deformation of erythrocytes (“sickling”). This can be triggered by any event associated with reduced oxygen tension.
- Hypoxia (e.g., at high altitudes)
- In homozygotes, up to 100% of the hemoglobin molecules are affected, leading to sickle cell formation under minimally decreased oxygen tension.
- In heterozygotes, sickling only occurs due to severe reduction in oxygen tension.
- Infections
- Dehydration
- Acidosis
- Sudden changes in temperature
- Stress
- Hypoxia (e.g., at high altitudes)
- Sickle cells lack elasticity and adhere to vascular endothelium, which disrupts microcirculation and causes vascular occlusion and subsequent tissue infarction.
- Hemolysis and the subsequent increased turnover of erythrocytes may increase the demand for folate, causing folate deficiency.
- Can present as macrocytic anemia
- Extravascular hemolysis and intravascular hemolysis are common and result in anemia.
Clinical features
Diagnostics
- Normal RBC indices (e.g. MCV)
- Not all red blood cells are sickled
Treatment
Overview
Infants and children
- Antibiotic prophylaxis against invasive pneumococcal disease until 5 years of age
- Hydroxyurea therapy regardless of clinical severity to minimize disease-related complications (First-line)
- Annual transcranial doppler to screen for stroke risk from 2 months till 16 years of age
Hydroxyurea therapy
Indications
- All infants > 9 months, children, and adolescents with sickle cell anemia regardless of symptom severity
- Adults with any of the following:
- Frequent (≥ 3 episodes/year) acute pain episodes or other vasoocclusive events
- Severe symptomatic anemia
- History of severe and/or recurrent acute chest syndrome
Mechanism of action
Stimulation of erythropoiesis and increased fetal hemoglobin
Complications
Splenic sequestration
- Pathophysiology: splenic vasoocclusion and entrapment and pooling of large amounts of blood in the spleen
- Clinical presentation
- Most commonly affects children < 5 years of age
- Acute left upper quadrant pain, splenomegaly
- Hypotension and/or hypovolemic shock, especially in infants
- Due to the trapping of blood in the spleen
- Symptoms of anemia (e.g., pallor, fatigue)
- Functional asplenia: Increased risk of infection with encapsulated bacteria (Streptococcus pneumoniae (most common), Neisseria meningitis, Haemophilus influenzae type b
- Supportive findings
- Anemia (Hb drop of ≥ 2 g/dL) with reticulocytosis
- Thrombocytopenia
- Acute management
- Immediate IV fluid resuscitation for hypovolemia
- Simple RBC transfusion in consultation with a sickle cell expert (avoid raising hemoglobin > 8 g/dL)